Physician

Justin Parschauer, D.O.

According to 2025 Medicare claims, Justin Parschauer, D.O. (NPI: 1073845921) practices ophthalmology in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is TULSA RETINA CONSULTANTS PLLC (NPI: 1205263126; TIN: 46-3683868) and primary practice location at 74114-1736.

Parschauer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,056 traditional Medicare patients, billed 110,903 HCPCS/CPT codes, and received $3,631,955 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 137 prescription claims across 55 beneficiaries totaling $7,763 in drug costs, led by Combigan (Brimonidine Tartrate/Timolol). Open Payments data shows 37 records totaling $41,962. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $243,644 to $3,631,955. In contrast, Part D prescription costs have declined steadily, from $13,651 to $7,763. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.6M2015 Medicare payment: $243,644 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $582,824 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $852,085 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,275,729 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,584,299 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,184,893 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,571,189 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,702,167 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,279,900 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,631,955 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155622,684$243,644
20167334,028$582,824
20179136,009$852,085
20181,2559,265$1,275,729
20191,23210,374$1,584,299
20209467,367$1,184,893
20211,0378,652$1,571,189
20221,0029,610$1,702,167
20231,20360,629$3,279,900
20241,056110,903$3,631,955

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$8.3K$17K2015 Drug cost: $13,651 (USD; Tot_Drug_Cst)2016 Drug cost: $16,664 (USD; Tot_Drug_Cst)2017 Drug cost: $11,493 (USD; Tot_Drug_Cst)2018 Drug cost: $11,238 (USD; Tot_Drug_Cst)2019 Drug cost: $13,071 (USD; Tot_Drug_Cst)2020 Drug cost: $9,372 (USD; Tot_Drug_Cst)2021 Drug cost: $8,664 (USD; Tot_Drug_Cst)2022 Drug cost: $10,997 (USD; Tot_Drug_Cst)2023 Drug cost: $12,365 (USD; Tot_Drug_Cst)2024 Drug cost: $7,763 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201570175$13,651
201677175$16,664
201753108$11,493
201868120$11,238
201950117$13,071
202038101$9,372
20213494$8,664
202246120$10,997
202367191$12,365
202455137$7,763

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more465550$96
67028Injection of drug into eye4961,882$88
92014Established patient complete exam of visual system525591$79
92134Imaging of retina9992,716$28
J2777Injection, faricimab-svoa, 0.1 mg354102,241$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CombiganBrimonidine Tartrate/Timolol13350$2,826
DifluprednateDifluprednate15267$1,789
Prednisolone AcetatePrednisolone Acetate391,057$1,417
Ketorolac TromethamineKetorolac Tromethamine29576$839

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$672Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.13$41,290Regeneron Pharmaceuticals, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Justin Parschauer, D.O.?

Tedicare shows public-source Medicare data for Justin Parschauer, D.O. (NPI 1073845921), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Justin Parschauer, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Justin Parschauer, D.O.?

Justin Parschauer, D.O. is linked to TULSA RETINA CONSULTANTS PLLC (billing NPI 1205263126) in the available physician profile data.

Does Justin Parschauer, D.O. have Open Payments data?

Justin Parschauer, D.O. has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.